Back to results
US 2026/0098015 A1Published application
Crystalline forms of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1h-imidazole
AssigneeRivus Pharmaceuticals, Inc.
InventorsMuralikrishna DUVVURI, Donald Herbert LAMUNYON, Micah Jeffrey BODNER
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to polymorphic forms of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1H-imidazole for treating various disorders or conditions, including mitochondria-related disorders or conditions and cardiovascular disorders or conditions.
Claims27
A crystalline form of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1H-imidazole having the structure:
2-28. (canceled)
30-77. (canceled)
A micronized crystalline form of 5-[(2,4-dinitrophenoxy)methyl]-1-methyl-2-nitro-1H-imidazole having the structure:
Dependencies are inferred from the claim text.